Intein-mediated recombinant expression of monomeric B22Asp desB30 insulin

BACKGROUND: Insulin controls hyperglycemia caused by diabetes, and virtually all treatments require exogenous insulin. However, the product’s extensive post-translational modifications have hindered the manufacture of recombinant insulin. RESULT: Here we report a novel production method for a monome...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Minmin, Zhang, Yunlong, Wu, Bingnan, Peng, Yanhao, Simair, Altaf Ahmed, Siegel, Geoffery W., Lu, Changrui, Chen, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953245/
https://www.ncbi.nlm.nih.gov/pubmed/31918694
http://dx.doi.org/10.1186/s12896-020-0598-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953245/
https://www.ncbi.nlm.nih.gov/pubmed/31918694
http://dx.doi.org/10.1186/s12896-020-0598-3

Ejemplares similares